Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs

SIMPLE SUMMARY: Immunotherapy with immune checkpoint inhibitors (ICI) has been a major advance in the management of cancers. To increase response rates, numerous new cancer immunotherapies are under development, to be used as monotherapies or as combination with existing ICIs. Lately, companion dogs...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Pantelyushin, Stanislav, Ranninger, Elisabeth, Guerrera, Diego, Hutter, Gregor, Maake, Caroline, Markkanen, Enni, Bettschart-Wolfensberger, Regula, Rohrer Bley, Carla, Läubli, Heinz, vom Berg, Johannes
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7918463/
https://ncbi.nlm.nih.gov/pubmed/33668625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040785
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы